Reduced Chemokine Receptor 9 on Intraepithelial Lymphocytes in Celiac Disease Suggests Persistent Epithelial Activation

Gastroenterology

Volumn 132, Issue 7, 2007, Pages 2371-2382

  Olaussen, Richard W ^a,c   Karlsson, Malin R ^a   Lundin, Knut E A ^b   Jahnsen, Jørgen ^d   Brandtzaeg, Per ^a,b   Farstad, Inger N ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR9; IONOMYCIN; NATURAL KILLER CELL RECEPTOR NKG2D; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ARTICLE; CELIAC DISEASE; CELL COUNT; DOWN REGULATION; DUODENUM BIOPSY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INTESTINE EPITHELIUM; JEJUNUM; LAMINA PROPRIA; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 34250011713     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.04.023     Document Type: Article

References (49)

1. Kolho K.L., Farkkila M.A., and Savilahti E. Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol 33 (1998) 1280-1283
2. Catassi C., Ratsch I.M., Fabiani E., Ricci S., Bordicchia F., Pierdomenico R., and Giorgi P.L. High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by antigliadin antibodies. Acta Paediatr 84 (1995) 672-676
3. Carlsson A.K., Axelsson I.E., Borulf S.K., Bredberg A.C., and Ivarsson S.A. Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 107 (2001) 42-45
4. Hoffenberg E.J., MacKenzie T., Barriga K.J., Eisenbarth G.S., Bao F., Haas J.E., Erlich H., Bugawan T.T., Sokol R.J., Taki I., Norris J.M., and Rewers M. A prospective study of the incidence of childhood celiac disease. J Pediatr 143 (2003) 308-314
5. Sollid L.M. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2 (2002) 647-655
6. Lundin K.E., Scott H., Hansen T., Paulsen G., Halstensen T.S., Fausa O., Thorsby E., and Sollid L.M. Gliadin-specific, HLA-DQ(α1*0501,β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 178 (1993) 187-196
7. Lundin K.E., Scott H., Fausa O., Thorsby E., and Sollid L.M. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 41 (1994) 285-291
8. Halstensen T.S., Scott H., Fausa O., and Brandtzaeg P. Gluten stimulation of coeliac mucosa in vitro induces activation (CD25) of lamina propria CD4+ T cells and macrophages but no crypt-cell hyperplasia. Scand J Immunol 38 (1993) 581-590
9. + phenotypes are increased in coeliac disease. Scand J Immunol 30 (1989) 665-672
10. Ebert E.C. Intra-epithelial lymphocytes: interferon-gamma production and suppressor/cytotoxic activities. Clin Exp Immunol 82 (1990) 81-85
11. Hayday A., Theodoridis E., Ramsburg E., and Shires J. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat Immunol 2 (2001) 997-1003
12. Halstensen T.S., and Brandtzaeg P. Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ α/β cells in the lamina propria but proliferation (Ki-67) of α/β and γ/δ cells in the epithelium. Eur J Immunol 23 (1993) 505-510
13. Wahab P.J., Meijer J.W., and Mulder C.J. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 118 (2002) 459-463
14. Selby W.S., Painter D., Collins A., Faulkner-Hogg K.B., and Loblay R.H. Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten. Scand J Gastroenterol 34 (1999) 909-914
15. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., Raulet D.H., Lanier L.L., Groh V., Spies T., Ebert E.C., Green P.H., and Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
16. Norment A.M., Bogatzki L.Y., Gantner B.N., and Bevan M.J. Murine CCR9, a chemokine receptor for thymus-expressed chemokine that is up-regulated following pre-TCR signaling. J Immunol 164 (2000) 639-648
17. Youn B.S., Kim C.H., Smith F.O., and Broxmeyer H.E. TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor. Blood 94 (1999) 2533-2536
18. Zaballos A., Gutierrez J., Varona R., Ardavin C., and Marquez G. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol 162 (1999) 5671-5675
19. Papadakis K.A., Prehn J., Nelson V., Cheng L., Binder S.W., Ponath P.D., Andrew D.P., and Targan S.R. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol 165 (2000) 5069-5076
20. Kunkel E.J., Campbell J.J., Haraldsen G., Pan J., Boisvert J., Roberts A.I., Ebert E.C., Vierra M.A., Goodman S.B., Genovese M.C., Wardlaw A.J., Greenberg H.B., Parker C.M., Butcher E.C., Andrew D.P., and Agace W.W. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 192 (2000) 761-768
21. Wurbel M.A., Philippe J.M., Nguyen C., Victorero G., Freeman T., Wooding P., Miazek A., Mattei M.G., Malissen M., Jordan B.R., Malissen B., Carrier A., and Naquet P. The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur J Immunol 30 (2000) 262-271
22. Zabel B.A., Agace W.W., Campbell J.J., Heath H.M., Parent D., Roberts A.I., Ebert E.C., Kassam N., Qin S., Zovko M., LaRosa G.J., Yang L.L., Soler D., Butcher E.C., Ponath P.D., Parker C.M., and Andrew D.P. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med 190 (1999) 1241-1256
23. + naive T cells recent thymic emigrants?. Scand J Immunol 54 (2001) 435-439
24. Papadakis K.A., Prehn J., Moreno S.T., Cheng L., Kouroumalis E.A., Deem R., Breaverman T., Ponath P.D., Andrew D.P., Green P.H., Hodge M.R., Binder S.W., and Targan S.R. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology 121 (2001) 246-254
25. + gut intraepithelial lymphocytes. Blood 98 (2001) 2626-2632
26. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., and Song S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 (2004) 527-538
27. Johansson-Lindbom B., Svensson M., Wurbel M.A., Malissen B., Marquez G., and Agace W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 198 (2003) 963-969
28. Mora J.R., Bono M.R., Manjunath N., Weninger W., Cavanagh L.L., Rosemblatt M., and Von Andrian U.H. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424 (2003) 88-93
29. Olaussen R.W., Johansen F.E., Lundin K.E., Jahnsen J., Brandtzaeg P., and Farstad I.N. Interferon-γ-secreting T cells localize to the epithelium in coeliac disease. Scand J Immunol 56 (2002) 652-664
30. Oberhuber G., Granditsch G., and Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11 (1999) 1185-1194
31. Roberts A.I., Lee L., Schwarz E., Groh V., Spies T., Ebert E.C., and Jabri B. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 167 (2001) 5527-5530
32. + and T cell receptor γδ subsets studied by flow cytometry. Acta Paediatr 89 (2000) 285-290
33. Gunther U., Holloway J.A., Gordon J.N., Knight A., Chance V., Hanley N.A., Wilson D.I., French R., Spencer J., Steer H., Anderson G., and MacDonald T.T. Phenotypic characterization of CD3-7+ cells in developing human intestine and an analysis of their ability to differentiate into T cells. J Immunol 174 (2005) 5414-5422
34. Jabri B., de Serre N.P., Cellier C., Evans K., Gache C., Carvalho C., Mougenot J.F., Allez M., Jian R., Desreumaux P., Colombel J.F., Matuchansky C., Cugnenc H., Lopez-Botet M., Vivier E., Moretta A., Roberts A.I., Ebert E.C., Guy-Grand D., Brousse N., Schmitz J., and Cerf-Bensussan N. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 118 (2000) 867-879
35. Hüe S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., Verkarre V., Fodil N., Bahram S., Cerf-Bensussan N., and Caillat-Zucman S. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21 (2004) 367-377
36. Nilsen E.M., Jahnsen F.L., Lundin K.E., Johansen F.E., Fausa O., Sollid L.M., Jahnsen J., Scott H., and Brandtzaeg P. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115 (1998) 551-563
37. Monteleone G., Pender S.L., Wathen N.C., and MacDonald T.T. Interferon-α drives T cell-mediated immunopathology in the intestine. Eur J Immunol 31 (2001) 2247-2255
38. Nilsen E.M., Lundin K.E., Krajci P., Scott H., Sollid L.M., and Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon γ. Gut 37 (1995) 766-776
39. Ebert E.C. Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology 115 (1998) 1439-1445
40. Collin P., Thorell L., Kaukinen K., and Mäki M. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease?. Aliment Pharmacol Ther 19 (2004) 1277-1283
41. Peraaho M., Kaukinen K., Paasikivi K., Sievanen H., Lohiniemi S., Maki M., and Collin P. Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Aliment Pharmacol Ther 17 (2003) 587-594
42. When is a coeliac a coeliac?. Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol 13 (2001) 1123-1128
43. Goerres M.S., Meijer J.W., Wahab P.J., Kerckhaert J.A., Groenen P.J., Van Krieken J.H., and Mulder C.J. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 18 (2003) 487-494
44. Mulder C.J., Wahab P.J., Moshaver B., and Meijer J.W. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma. Scand J Gastroenterol Suppl (2000) 32-37
45. Farstad I.N., Johansen F.E., Vlatkovic J., Jahnsen J., Scott H., Fausa O., Bjorneklett A., Brandtzaeg P., and Halstensen T.S. Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut 51 (2002) 372-378
46. Youn B.S., Yu K.Y., Oh J., Lee J., Lee T.H., and Broxmeyer H.E. Role of the CC chemokine receptor 9/TECK interaction in apoptosis. Apoptosis 7 (2002) 271-276
47. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., and Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727-729
48. Maiuri L., Ciacci C., Auricchio S., Brown V., Quaratino S., and Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119 (2000) 996-1006
49. Mention J.J., Ben Ahmed M., Begue B., Barbe U., Verkarre V., Asnafi V., Colombel J.F., Cugnenc P.H., Ruemmele F.M., McIntyre E., Brousse N., Cellier C., and Cerf-Bensussan N. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125 (2003) 730-745